Industry Research Reports
Global Glimepiride API Market Research Report 2024
Industry: Chemical & Material
Published Date: 2024-01-10
Pages: 103 Pages
Report ld: 2404677
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
The global Glimepiride API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glimepiride API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glimepiride API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glimepiride API include Dr. Reddy’s Laboratories Ltd., SANOFI Active Ingredient Solutions, Dishman Carbogen Amcis, Glenmark Pharmaceuticals, Sharon Bio-Medicine Limited, Supra Chemicals, Rakshit Drugs, Estechpharma Co., Ltd. and Nishchem International Pvt. Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glimepiride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glimepiride API.
MARKET SEGMENTATION
By Company
- Dr. Reddy’s Laboratories Ltd.
- SANOFI Active Ingredient Solutions
- Dishman Carbogen Amcis
- Glenmark Pharmaceuticals
- Sharon Bio-Medicine Limited
- Supra Chemicals
- Rakshit Drugs
- Estechpharma Co., Ltd.
- Nishchem International Pvt. Ltd
- Nexchem Pharmaceutical Co, ltd
- Maps Laboratories Private Limited
- CAD Middle East Pharmaceutical
- Hanways Chempharm Co., Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity<98%
Segment by Application
- Glimepiride Tablets
- Others
REPORT SCOPE
The Glimepiride API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glimepiride API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glimepiride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glimepiride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Glimepiride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Glimepiride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Glimepiride API Market Overview
1.1 Product Definition
1.2 Glimepiride API Segment by Type
1.2.1 Global Glimepiride API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Glimepiride API Segment by Application
1.3.1 Global Glimepiride API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Glimepiride Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Glimepiride API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Glimepiride API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Glimepiride API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Glimepiride API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Glimepiride API Production Market Share by Manufacturers (2019-2024)
2.2 Global Glimepiride API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Glimepiride API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Glimepiride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Glimepiride API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Glimepiride API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Glimepiride API, Product Offered and Application
2.8 Global Key Manufacturers of Glimepiride API, Date of Enter into This Industry
2.9 Glimepiride API Market Competitive Situation and Trends
2.9.1 Glimepiride API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Glimepiride API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Glimepiride API Production by Region
3.1 Global Glimepiride API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Glimepiride API Production Value by Region (2019-2030)
3.2.1 Global Glimepiride API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Glimepiride API by Region (2025-2030)
3.3 Global Glimepiride API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Glimepiride API Production by Region (2019-2030)
3.4.1 Global Glimepiride API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Glimepiride API by Region (2025-2030)
3.5 Global Glimepiride API Market Price Analysis by Region (2019-2024)
3.6 Global Glimepiride API Production and Value, Year-over-Year Growth
3.6.1 India Glimepiride API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Glimepiride API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Glimepiride API Production Value Estimates and Forecasts (2019-2030)
3.6.4 South Korea Glimepiride API Production Value Estimates and Forecasts (2019-2030)
4 Glimepiride API Consumption by Region
4.1 Global Glimepiride API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Glimepiride API Consumption by Region (2019-2030)
4.2.1 Global Glimepiride API Consumption by Region (2019-2024)
4.2.2 Global Glimepiride API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Glimepiride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Glimepiride API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Glimepiride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Glimepiride API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Glimepiride API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Glimepiride API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Glimepiride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Glimepiride API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Glimepiride API Production by Type (2019-2030)
5.1.1 Global Glimepiride API Production by Type (2019-2024)
5.1.2 Global Glimepiride API Production by Type (2025-2030)
5.1.3 Global Glimepiride API Production Market Share by Type (2019-2030)
5.2 Global Glimepiride API Production Value by Type (2019-2030)
5.2.1 Global Glimepiride API Production Value by Type (2019-2024)
5.2.2 Global Glimepiride API Production Value by Type (2025-2030)
5.2.3 Global Glimepiride API Production Value Market Share by Type (2019-2030)
5.3 Global Glimepiride API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Glimepiride API Production by Application (2019-2030)
6.1.1 Global Glimepiride API Production by Application (2019-2024)
6.1.2 Global Glimepiride API Production by Application (2025-2030)
6.1.3 Global Glimepiride API Production Market Share by Application (2019-2030)
6.2 Global Glimepiride API Production Value by Application (2019-2030)
6.2.1 Global Glimepiride API Production Value by Application (2019-2024)
6.2.2 Global Glimepiride API Production Value by Application (2025-2030)
6.2.3 Global Glimepiride API Production Value Market Share by Application (2019-2030)
6.3 Global Glimepiride API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Glimepiride API Corporation Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Glimepiride API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 SANOFI Active Ingredient Solutions
7.2.1 SANOFI Active Ingredient Solutions Glimepiride API Corporation Information
7.2.2 SANOFI Active Ingredient Solutions Glimepiride API Product Portfolio
7.2.3 SANOFI Active Ingredient Solutions Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 SANOFI Active Ingredient Solutions Main Business and Markets Served
7.2.5 SANOFI Active Ingredient Solutions Recent Developments/Updates
7.3 Dishman Carbogen Amcis
7.3.1 Dishman Carbogen Amcis Glimepiride API Corporation Information
7.3.2 Dishman Carbogen Amcis Glimepiride API Product Portfolio
7.3.3 Dishman Carbogen Amcis Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Dishman Carbogen Amcis Main Business and Markets Served
7.3.5 Dishman Carbogen Amcis Recent Developments/Updates
7.4 Glenmark Pharmaceuticals
7.4.1 Glenmark Pharmaceuticals Glimepiride API Corporation Information
7.4.2 Glenmark Pharmaceuticals Glimepiride API Product Portfolio
7.4.3 Glenmark Pharmaceuticals Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.5 Sharon Bio-Medicine Limited
7.5.1 Sharon Bio-Medicine Limited Glimepiride API Corporation Information
7.5.2 Sharon Bio-Medicine Limited Glimepiride API Product Portfolio
7.5.3 Sharon Bio-Medicine Limited Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Sharon Bio-Medicine Limited Main Business and Markets Served
7.5.5 Sharon Bio-Medicine Limited Recent Developments/Updates
7.6 Supra Chemicals
7.6.1 Supra Chemicals Glimepiride API Corporation Information
7.6.2 Supra Chemicals Glimepiride API Product Portfolio
7.6.3 Supra Chemicals Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Supra Chemicals Main Business and Markets Served
7.6.5 Supra Chemicals Recent Developments/Updates
7.7 Rakshit Drugs
7.7.1 Rakshit Drugs Glimepiride API Corporation Information
7.7.2 Rakshit Drugs Glimepiride API Product Portfolio
7.7.3 Rakshit Drugs Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Rakshit Drugs Main Business and Markets Served
7.7.5 Rakshit Drugs Recent Developments/Updates
7.8 Estechpharma Co., Ltd.
7.8.1 Estechpharma Co., Ltd. Glimepiride API Corporation Information
7.8.2 Estechpharma Co., Ltd. Glimepiride API Product Portfolio
7.8.3 Estechpharma Co., Ltd. Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Estechpharma Co., Ltd. Main Business and Markets Served
7.7.5 Estechpharma Co., Ltd. Recent Developments/Updates
7.9 Nishchem International Pvt. Ltd
7.9.1 Nishchem International Pvt. Ltd Glimepiride API Corporation Information
7.9.2 Nishchem International Pvt. Ltd Glimepiride API Product Portfolio
7.9.3 Nishchem International Pvt. Ltd Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Nishchem International Pvt. Ltd Main Business and Markets Served
7.9.5 Nishchem International Pvt. Ltd Recent Developments/Updates
7.10 Nexchem Pharmaceutical Co, ltd
7.10.1 Nexchem Pharmaceutical Co, ltd Glimepiride API Corporation Information
7.10.2 Nexchem Pharmaceutical Co, ltd Glimepiride API Product Portfolio
7.10.3 Nexchem Pharmaceutical Co, ltd Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Nexchem Pharmaceutical Co, ltd Main Business and Markets Served
7.10.5 Nexchem Pharmaceutical Co, ltd Recent Developments/Updates
7.11 Maps Laboratories Private Limited
7.11.1 Maps Laboratories Private Limited Glimepiride API Corporation Information
7.11.2 Maps Laboratories Private Limited Glimepiride API Product Portfolio
7.11.3 Maps Laboratories Private Limited Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Maps Laboratories Private Limited Main Business and Markets Served
7.11.5 Maps Laboratories Private Limited Recent Developments/Updates
7.12 CAD Middle East Pharmaceutical
7.12.1 CAD Middle East Pharmaceutical Glimepiride API Corporation Information
7.12.2 CAD Middle East Pharmaceutical Glimepiride API Product Portfolio
7.12.3 CAD Middle East Pharmaceutical Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 CAD Middle East Pharmaceutical Main Business and Markets Served
7.12.5 CAD Middle East Pharmaceutical Recent Developments/Updates
7.13 Hanways Chempharm Co., Limited
7.13.1 Hanways Chempharm Co., Limited Glimepiride API Corporation Information
7.13.2 Hanways Chempharm Co., Limited Glimepiride API Product Portfolio
7.13.3 Hanways Chempharm Co., Limited Glimepiride API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Hanways Chempharm Co., Limited Main Business and Markets Served
7.13.5 Hanways Chempharm Co., Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Glimepiride API Industry Chain Analysis
8.2 Glimepiride API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Glimepiride API Production Mode & Process
8.4 Glimepiride API Sales and Marketing
8.4.1 Glimepiride API Sales Channels
8.4.2 Glimepiride API Distributors
8.5 Glimepiride API Customers
9 Glimepiride API Market Dynamics
9.1 Glimepiride API Industry Trends
9.2 Glimepiride API Market Drivers
9.3 Glimepiride API Market Challenges
9.4 Glimepiride API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Glimepiride API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Glimepiride API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Glimepiride API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Glimepiride API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Glimepiride API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Glimepiride API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Glimepiride API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Glimepiride API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glimepiride API as of 2023)
Table 10. Global Market Glimepiride API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Glimepiride API Production Sites and Area Served
Table 12. Manufacturers Glimepiride API Product Types
Table 13. Global Glimepiride API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Glimepiride API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Glimepiride API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Glimepiride API Production Value Market Share by Region (2019-2024)
Table 18. Global Glimepiride API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Glimepiride API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Glimepiride API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Glimepiride API Production (Ton) by Region (2019-2024)
Table 22. Global Glimepiride API Production Market Share by Region (2019-2024)
Table 23. Global Glimepiride API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Glimepiride API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Glimepiride API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Glimepiride API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Glimepiride API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Glimepiride API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Glimepiride API Consumption Market Share by Region (2019-2024)
Table 30. Global Glimepiride API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Glimepiride API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Glimepiride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Glimepiride API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Glimepiride API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Glimepiride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Glimepiride API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Glimepiride API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Glimepiride API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Glimepiride API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Glimepiride API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Glimepiride API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Glimepiride API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Glimepiride API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Glimepiride API Production (Ton) by Type (2019-2024)
Table 45. Global Glimepiride API Production (Ton) by Type (2025-2030)
Table 46. Global Glimepiride API Production Market Share by Type (2019-2024)
Table 47. Global Glimepiride API Production Market Share by Type (2025-2030)
Table 48. Global Glimepiride API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Glimepiride API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Glimepiride API Production Value Share by Type (2019-2024)
Table 51. Global Glimepiride API Production Value Share by Type (2025-2030)
Table 52. Global Glimepiride API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Glimepiride API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Glimepiride API Production (Ton) by Application (2019-2024)
Table 55. Global Glimepiride API Production (Ton) by Application (2025-2030)
Table 56. Global Glimepiride API Production Market Share by Application (2019-2024)
Table 57. Global Glimepiride API Production Market Share by Application (2025-2030)
Table 58. Global Glimepiride API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Glimepiride API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Glimepiride API Production Value Share by Application (2019-2024)
Table 61. Global Glimepiride API Production Value Share by Application (2025-2030)
Table 62. Global Glimepiride API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Glimepiride API Price (US$/Ton) by Application (2025-2030)
Table 64. Dr. Reddy’s Laboratories Ltd. Glimepiride API Corporation Information
Table 65. Dr. Reddy’s Laboratories Ltd. Specification and Application
Table 66. Dr. Reddy’s Laboratories Ltd. Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
Table 68. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
Table 69. SANOFI Active Ingredient Solutions Glimepiride API Corporation Information
Table 70. SANOFI Active Ingredient Solutions Specification and Application
Table 71. SANOFI Active Ingredient Solutions Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. SANOFI Active Ingredient Solutions Main Business and Markets Served
Table 73. SANOFI Active Ingredient Solutions Recent Developments/Updates
Table 74. Dishman Carbogen Amcis Glimepiride API Corporation Information
Table 75. Dishman Carbogen Amcis Specification and Application
Table 76. Dishman Carbogen Amcis Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Dishman Carbogen Amcis Main Business and Markets Served
Table 78. Dishman Carbogen Amcis Recent Developments/Updates
Table 79. Glenmark Pharmaceuticals Glimepiride API Corporation Information
Table 80. Glenmark Pharmaceuticals Specification and Application
Table 81. Glenmark Pharmaceuticals Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Glenmark Pharmaceuticals Main Business and Markets Served
Table 83. Glenmark Pharmaceuticals Recent Developments/Updates
Table 84. Sharon Bio-Medicine Limited Glimepiride API Corporation Information
Table 85. Sharon Bio-Medicine Limited Specification and Application
Table 86. Sharon Bio-Medicine Limited Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Sharon Bio-Medicine Limited Main Business and Markets Served
Table 88. Sharon Bio-Medicine Limited Recent Developments/Updates
Table 89. Supra Chemicals Glimepiride API Corporation Information
Table 90. Supra Chemicals Specification and Application
Table 91. Supra Chemicals Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Supra Chemicals Main Business and Markets Served
Table 93. Supra Chemicals Recent Developments/Updates
Table 94. Rakshit Drugs Glimepiride API Corporation Information
Table 95. Rakshit Drugs Specification and Application
Table 96. Rakshit Drugs Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Rakshit Drugs Main Business and Markets Served
Table 98. Rakshit Drugs Recent Developments/Updates
Table 99. Estechpharma Co., Ltd. Glimepiride API Corporation Information
Table 100. Estechpharma Co., Ltd. Specification and Application
Table 101. Estechpharma Co., Ltd. Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Estechpharma Co., Ltd. Main Business and Markets Served
Table 103. Estechpharma Co., Ltd. Recent Developments/Updates
Table 104. Nishchem International Pvt. Ltd Glimepiride API Corporation Information
Table 105. Nishchem International Pvt. Ltd Specification and Application
Table 106. Nishchem International Pvt. Ltd Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Nishchem International Pvt. Ltd Main Business and Markets Served
Table 108. Nishchem International Pvt. Ltd Recent Developments/Updates
Table 109. Nexchem Pharmaceutical Co, ltd Glimepiride API Corporation Information
Table 110. Nexchem Pharmaceutical Co, ltd Specification and Application
Table 111. Nexchem Pharmaceutical Co, ltd Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Nexchem Pharmaceutical Co, ltd Main Business and Markets Served
Table 113. Nexchem Pharmaceutical Co, ltd Recent Developments/Updates
Table 114. Maps Laboratories Private Limited Glimepiride API Corporation Information
Table 115. Maps Laboratories Private Limited Specification and Application
Table 116. Maps Laboratories Private Limited Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Maps Laboratories Private Limited Main Business and Markets Served
Table 118. Maps Laboratories Private Limited Recent Developments/Updates
Table 119. CAD Middle East Pharmaceutical Glimepiride API Corporation Information
Table 120. CAD Middle East Pharmaceutical Specification and Application
Table 121. CAD Middle East Pharmaceutical Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. CAD Middle East Pharmaceutical Main Business and Markets Served
Table 123. CAD Middle East Pharmaceutical Recent Developments/Updates
Table 124. Hanways Chempharm Co., Limited Glimepiride API Corporation Information
Table 125. Hanways Chempharm Co., Limited Specification and Application
Table 126. Hanways Chempharm Co., Limited Glimepiride API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Hanways Chempharm Co., Limited Main Business and Markets Served
Table 128. Hanways Chempharm Co., Limited Recent Developments/Updates
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Glimepiride API Distributors List
Table 132. Glimepiride API Customers List
Table 133. Glimepiride API Market Trends
Table 134. Glimepiride API Market Drivers
Table 135. Glimepiride API Market Challenges
Table 136. Glimepiride API Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glimepiride API
Figure 2. Global Glimepiride API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Glimepiride API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Glimepiride API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Glimepiride API Market Share by Application: 2023 VS 2030
Figure 8. Glimepiride Tablets
Figure 9. Others
Figure 10. Global Glimepiride API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Glimepiride API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Glimepiride API Production Capacity (Ton) & (2019-2030)
Figure 13. Global Glimepiride API Production (Ton) & (2019-2030)
Figure 14. Global Glimepiride API Average Price (US$/Ton) & (2019-2030)
Figure 15. Glimepiride API Report Years Considered
Figure 16. Glimepiride API Production Share by Manufacturers in 2023
Figure 17. Glimepiride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Glimepiride API Revenue in 2023
Figure 19. Global Glimepiride API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Glimepiride API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Glimepiride API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 22. Global Glimepiride API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. India Glimepiride API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Glimepiride API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Glimepiride API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. South Korea Glimepiride API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Glimepiride API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 28. Global Glimepiride API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 30. North America Glimepiride API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. U.S. Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. Europe Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 34. Europe Glimepiride API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. France Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. U.K. Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. Italy Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. Russia Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Asia Pacific Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 41. Asia Pacific Glimepiride API Consumption Market Share by Regions (2019-2030)
Figure 42. China Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. Japan Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. South Korea Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. China Taiwan Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. Southeast Asia Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. India Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Latin America, Middle East & Africa Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 49. Latin America, Middle East & Africa Glimepiride API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Brazil Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. Turkey Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. GCC Countries Glimepiride API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 54. Global Production Market Share of Glimepiride API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Glimepiride API by Type (2019-2030)
Figure 56. Global Glimepiride API Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Glimepiride API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Glimepiride API by Application (2019-2030)
Figure 59. Global Glimepiride API Price (US$/Ton) by Application (2019-2030)
Figure 60. Glimepiride API Value Chain
Figure 61. Glimepiride API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Glimepiride API market?
The top companies in the global Glimepiride API market are Dr. Reddy’s Laboratories Ltd.、SANOFI Active Ingredient Solutions、Dishman Carbogen Amcis.
Related Reports
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glimepiride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 142
USD 3950.00
(Single User License)
Global Glimepiride API Market Research Report 2026
The global Glimepiride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 145
USD 2900.00
(Single User License)
Global Glimepiride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Glimepiride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 162
USD 4900.00
(Single User License)
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Glimepiride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 116
USD 3950.00
(Single User License)
Global Glimepiride API Market Research Report 2025
The global market for Glimepiride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 102
USD 2900.00
(Single User License)
Global Glimepiride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glimepiride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 91
USD 4250.00
(Single User License)
Global Glimepiride API Market Insights, Forecast to 2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-04-15
Pages: 114
USD 4900.00
(Single User License)
Glimepiride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published Date: 2024-02-23
Pages: 127
USD 3950.00
(Single User License)
Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Glimepiride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 142
USD 3950.00 (Single User License)Global Glimepiride API Market Research Report 2026
The global Glimepiride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 145
USD 2900.00 (Single User License)Global Glimepiride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Glimepiride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 162
USD 4900.00 (Single User License)Glimepiride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Glimepiride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 116
USD 3950.00 (Single User License)Global Glimepiride API Market Research Report 2025
The global market for Glimepiride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 102
USD 2900.00 (Single User License)Global Glimepiride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Glimepiride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 91
USD 4250.00 (Single User License)Global Glimepiride API Market Insights, Forecast to 2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-04-15
Pages: 114
USD 4900.00 (Single User License)Glimepiride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Glimepiride is a long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.
Published: 2024-02-23
Pages: 127
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now